CYP4F2 genetic polymorphisms are associated with coronary heart disease in a Chinese population

被引：0
|
作者：
Changqing Yu
Qingkai Yan
Chunjiang Fu
Weibin Shi
Hongyong Wang
Chunyu Zeng
Xukai Wang
机构：
[1] The Third Military Medical University,Department of Cardiology, Daping Hospital
[2] Chongqing Institute of Cardiology,undefined
来源：
Lipids in Health and Disease | / 13卷
关键词：
Coronary heart disease; CYP4F2 gene; Single nucleotide polymorphism;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Genetic Variants of CYP4F2 Associated with Ischemic Stroke Susceptibility in the Han Population from Southern China
    Huang, Kang
    Ma, Tianyi
    Li, Qiang
    Zhou, Yilei
    Qin, Ting
    Zhong, Zanrui
    Tang, Shilin
    Zhang, Wei
    Zhong, Jianghua
    Lu, Shijuan
    PHARMACOGENOMICS & PERSONALIZED MEDICINE, 2023, 16 : 599 - 607
  • [22] Effects of Ketoconazole, a CYP4F2 Inhibitor, and CYP4F2*3 Genetic Polymorphism on Pharmacokinetics of Vitamin K1
    Park, Jin-Woo
    Kim, Kyoung-Ah
    Park, Ji-Young
    JOURNAL OF CLINICAL PHARMACOLOGY, 2019, 59 (11): : 1453 - 1461
  • [23] Genetic determinants of acenocoumarol and warfarin maintenance dose requirements in Slavic population: A potential role of CYP4F2 and GGCX polymorphisms
    Wypasek, Ewa
    Branicka, Agnieszka
    Awsiuk, Magdalena
    Sadowski, Jerzy
    Undas, Anetta
    THROMBOSIS RESEARCH, 2014, 134 (03) : 604 - 609
  • [24] Polymorphisms in VKORC1, CYP2C9, and CYP4F2 and Warfarin Dose in the Pediatric Population
    Vear, Susan I.
    Ayers, Gregory D.
    Stein, C. Michael
    Ho, Richard H.
    BLOOD, 2012, 120 (21)
  • [25] Effects of CYP4F2 genetic polymorphisms and haplotypes on clinical outcomes in patients initiated on warfarin therapy
    Zhang, Jieying Eunice
    Jorgensen, Andrea L.
    Alfirevic, Ana
    Williamson, Paula R.
    Toh, Cheng H.
    Park, Brian Kevin
    Pirmohamed, Munir
    PHARMACOGENETICS AND GENOMICS, 2009, 19 (10): : 781 - 789
  • [26] Novel polymorphisms in CYP4A22 associated with susceptibility to coronary heart disease
    Kang Huang
    Tianyi Ma
    Qiang Li
    Zanrui Zhong
    Yilei Zhou
    Wei Zhang
    Ting Qin
    Shilin Tang
    Jianghua Zhong
    Shijuan Lu
    BMC Medical Genomics, 17
  • [27] Novel polymorphisms in CYP4A22 associated with susceptibility to coronary heart disease
    Huang, Kang
    Ma, Tianyi
    Li, Qiang
    Zhong, Zanrui
    Zhou, Yilei
    Zhang, Wei
    Qin, Ting
    Tang, Shilin
    Zhong, Jianghua
    Lu, Shijuan
    BMC MEDICAL GENOMICS, 2024, 17 (01)
  • [28] PharmVar GeneFocus: CYP4F2
    Zubiaur, Pablo
    Rodriguez-Antona, Cristina
    Boone, Erin C.
    Daly, Ann K.
    Tsermpini, Evangelia Eirini
    Khasawneh, Lubna Q.
    Sangkuhl, Katrin
    Duconge, Jorge
    Botton, Mariana R.
    Savieo, Jessica
    Nofziger, Charity
    Whirl-Carrillo, Michelle
    Klein, Teri E.
    Gaedigk, Andrea
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024, 116 (04) : 963 - 975
  • [29] Correlation between single nucleotide polymorphisms in CYP4F2 and warfarin dosing in chinese valve replacement patients
    Jie-Hui Li
    Guo-Guo Ma
    Shu-Qiang Zhu
    Hao Yan
    Yong-Bing Wu
    Jian-Jun Xu
    Journal of Cardiothoracic Surgery, 7
  • [30] CDKN2BAS polymorphisms are associated with coronary heart disease risk a Han Chinese population
    Zhao, Qingbin
    Liao, Shudan
    Wei, Huiyi
    Liu, Dandan
    Li, Jingjie
    Zhang, Xiyang
    Yan, Mengdan
    Jin, Tianbo
    ONCOTARGET, 2016, 7 (50) : 82046 - 82054
12345